Ignite Creation Date:
2024-05-06 @ 9:46 AM
Last Modification Date:
2024-10-26 @ 12:19 PM
Study NCT ID:
NCT03066869
Status:
UNKNOWN
Last Update Posted:
2019-09-12
First Post:
2016-12-30
Brief Title:
Efficacy and Safety of HP ACTHAR GEL in Adults With Retinal Vasculitis
Sponsor:
Ocular Immunology and Uveitis Foundation
Organization:
Ocular Immunology and Uveitis Foundation
Study Overview
Official Title:
Open-label Single-center Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection HP ACTHAR GEL in the Treatment of Adults With Non-infectious Retinal Vasculitis
Status:
UNKNOWN
Status Verified Date:
2019-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the short- and long-term efficacy and safety of Acthar for the treatment of adults with non-infectious retinal vasculitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None